FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine, namely to oncology, and can be used for treatment of cancer in a human patient. For this purpose an efficient amount of an antibody against VEGF (bevacizumab) is introduced to the patient. Simultaneously the patient is monitored for gastrointestinal perforation. Also claimed are an industrial product and a set for treating cancer in the human patient.
EFFECT: group of inventions provides extension of an arsenal of anti-tumour medications.
32 cl, 5 tbl, 7 dwg, 2 ex
